CompletedPhase 2NCT02689986
Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Studying Autoimmune hemolytic anemia, cold type
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Helse Fonna
- Principal Investigator
- Sigbjorn Berentsen, MD, PhDDepartment of Research and Innovation, Haugesund Hospital
- Intervention
- Bendamustine, Rituximab(drug)
- Enrollment
- 43 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2016
Study locations (8)
- Herlev University Hospital, Copenhagen, Denmark
- Turku University Hospital, Turku, Finland
- Haukeland University Hospital, Bergen, Norway
- Vestre Viken Hospital, Drammen, Norway
- Haugesund Hospital, Haugesund, Norway
- Akershus University Hospital, Nordbyhagen, Norway
- Oslo University Hospital, Oslo, Norway
- St Olav University Hospital, Trondheim, Norway
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02689986 on ClinicalTrials.govOther trials for Autoimmune hemolytic anemia, cold type
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07202117PLLA and CaHA-R for Aesthetic RejuvenationErevna Innovations Inc.
- RECRUITINGNCT05931718Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune NeutropeniaFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico